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The pure reticulocyte lipoxygenase converts 5,15-DiHETE via a lipoxygenase reaction to 5,14,15-trihy- 
droxy-6,8,10, IZeicosatetraenoic acid (a lipoxin B isomer) as shown by GC/MS analysis of its trimethylsilyl 
ether. With arachidonic acid, 15HETE and 1 S-HETE methyl ester this lipoxin B isomer was also formed. 
The results presented here indicate that pure mammalian lipoxygenases are able to form lipoxins via sequen- 
tial multiple oxygenation of arachidonic acid or its hydroxy derivatives. 
Lipoxygenase ikfultiple oxygenation Lipoxin 
1. INTRODUCTION 
In 1984 Serhan et al. [1,2] described the forma- 
tion of trihydroxyeicosanoids containing a con- 
jugated tetraene system, called lipoxins, by 
polymorphonuclear leukocytes. As concluded 
from their steric structure which was elucidated by 
co-chromatography with authentic standards [3-51 
most of the lipoxin A isomers, in particular those 
containing an all-trans conjugated tetraene system, 
were formed via hydrolysis of an epoxy in- 
termediate [3,6]. Conflicting results, however, 
were reported concerning the steric structure and 
consequently the biosynthetic pathway of lipoxin B 
isomers [7,8]. Recently Morris et al. [9] identified 
one-fifth of the lipoxin B isomers formed by 
leukocytes as 5S,14R,15S trihydroxy-6&8Z,lOE, 
Abbreviations: 15H(P)ETE, 15-hydro(pero)xy- 
5,8,11,13(Z,Z,Z,E)-eicosatetraenoicacid; 5,15-DiHETE, 
5,15 - dihydroxy - 6,8,11,13(E,Z,Z,E) - eicosatetraenoic 
acid; RP-HPLC, reversed-phase high-pressure liquid 
chromatography; SP-HPLC, straight-phase high- 
pressure liquid chromatography; GUMS, gas chroma- 
tography/mass pectroscopy 
LX-eicosatetraenoic acid. This product meets the 
structural requirements of a triple oxygenation 
product of arachidonic acid, but is biosynthesized 
via enzymatic epoxide hydrolysis [lo]. 
Two years ago we reported that the lipox- 
ygenases from reticulocytes and soybeans convert 
their reduced double oxygenation product, 
5,15-DiHETE, to trihydroxyeicosanoids contain- 
ing a conjugated tetraene system [l 11. 
Here, it is shown that the main product formed 
during the 5,15-DiHETE oxygenation by 
reticulocyte lipoxygenase is 5,14,15_trihydroxy- 
6,8,10,12-eicosatetraenoic acid (a lipoxin B 
isomer). (See Note Added in Proof.) 
2. MATERIALS AND METHODS 
2.1. Chemicals 
The chemicals used were obtained from the 
following sources: 5,8,ll,lCeicosatetraenoic acid 
(9OYo pure), soybean lipoxygenase (type IV) and 
bis(trimethylsilyl)trifluoroacetamide (BSTFA) 
from Serva (FRG); sodium borohydride from 
Merck (FRG). 
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2.2. Preparations 
Reticulocyte lipoxygenase was prepared to 
homogeneity as described in [ 121. 1 SLs-HETE was 
prepared from arachidonic acid with soybean 
lipoxygenase as described in [13] except that the 
reduction of 15HPETE formed was performed 
with sodium borohydride prior to silica gel column 
chromatography. 5,15-DiHETE was prepared with 
a modified method according to [14] and subse- 
quent SP-HPLC separation. 1 SLs-HETE was used 
as substrate. The chemical nature of 15-HETE and 
5,15-DiHETE prepared was confirmed by UV and 
IR spectroscopy and GC/MS analysis. 
2.3. Analytics 
RP-HPLC was performed with a Du Pont 8800 
instrument equipped with a Zorbax-ODS RP- 
HPLC column (250 x 4.6 mm; 5 pm particle size). 
The methyl esters of the trihydroxyeicosanoids 
were eluted with a solvent system of 
methanol/water (60:40, v/v), flow rate 1 ml/min. 
The absorbance at 300 nm was recorded. GC/MS 
analysis was performed with a Hewlett Packard 
5995 A GC/MS system equipped with an SE 54 
column (25 m x 0.24 mm). Samples were applied 
with a home-made on-column injector. The 
trimethylsilyl ether of the trihydroxyeicosanoid 
methyl ester was eluted with a carrier gas (helium) 
flow of 1.8 ml/min. Initially the temperature was 
held for 1 min at 200°C and then increased at a 
0.1 
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Fig.1. Formation of lipoxins during the oxygenation of
5,15DiHETE. Reticulocyte lipoxygenase (8 nkat/ml 
linoleate oxygenase activity) was incubated with 
5,15-DiHETE (15 PM) in 0.1 M phosphate buffer, pH 
7.4 at 4°C. Repeated spectra of the reaction mixture 
were recorded in the range of 280-450 nm with a time 
interval of 5 min. 
rate of S”C/min up to 260°C. The interface 
temperature was 270°C. The trihydroxyeicosanoid 
derivatives were eluted at 5.1 min. An electron 
energy of 70 eV was used. 
2.4. Miscellaneous 
The molar absorption coefficients used were as 
follows: 15-HETE, 6234 = 28000 (M-cm)-’ [15]; 
5,15-DiHETE, ~242 = 40000 (M-cm)-’ [14]; lipox- 
ins, 6301 = 50000 (M-cm)-’ [2]. For RP-HPLC the 
free hydroxy fatty acids were methylated with 
diazomethane in ether. For GC/MS analysis the 
methylated hydroxy fatty acids were converted to 
their corresponding trimethylsilyl ethers by reac- 
tion with BSTFA (15 min at 60°C). UV spec- 
trophotometric measurements were performed 
with a Pye Unicam SP 1750 spectrophotometer. 
3. RESULTS 
The pure reticulocyte lipoxygenase converted 
5,15-DiHETE to product(s) possessing a con- 
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Fig.2. RP-HPLC of lipoxins formed by the reticulocyte 
lipoxygenase during 5,15-DiHETE oxygenation. 
Incubation conditions as in fig.1. Total volume of the 
preparation 1 1. After the reaction had ceased (no 
further spectral changes) the mixture was acidified to pH 
3 and twice extracted with twice the volume of diethyl 
ether. The organic extracts were dried over anhydrous 
sodium sulfate, the solvent was evaporated under 
reduced pressure, the products were dissolved in 200,~l 
methanol and methylated with ethereal diazomethane. 
Unconverted 5,15-DiHETE was removed by SP-HPLC. 
The fractions containing conjugated tetraenes were 
pooled and an aliquot was subjected to RP-HPLC as 
described in section 2. Absorbance at 300 nm was 
recorded. 
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jugated tetraene system as indicated by the maxima 
of strong UV absorbance at 301 and 315 nm 
0.8 (fig.1). After the reaction had ceased (no further 
increase in absorbance at 315 nm) the products 
0.6 were extracted with diethyl ether and subjected to 
4 SP-HPLC to remove unconverted 5,15-DiHETE. 
0.4 Products with the spectral properties of con- 
jugated tetraenes were collected, concentrated, 
a2 methylated with diazomethane and subjected to 
RP-HPLC analysis. As seen from fig.2, four 
products absorbing at 300 nm were separated but 
280 320 360 A(nm) only products III and IV show the suectral uroper- 
Fig.3. UV-spectrum of product III dissolved in 
methanol. 
ties of conjugated tetraenes. The main pro&c; III 
was prepared by RP-HPLC and its UV-spectrum 
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Fig.4. GC/MS analysis of product III. GC/MS analysis was performed as described in section 2. Inset: fragmentation 
pattern of product III indicating the positions of the OH groups. 
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was recorded (fig.3). The maxima of strong absor- 
bance at 286, 301 and 315 nm point to the con- 
jugated tetraene system 161. Product III was 
silylated and subjected to GClMS analysis. Fig.4 
shows a representative mass spectrogram of it. It is 
evident that product III is a trihydroxyeicosanoid 
containing four double bonds indicated by the ions 
at m/z 582 (M+), 567 (Mf - 15, loss of CH3), 492 
(M+ - 90, loss of TMS-OH), 482 (M+ - 100, rear- 
rangement followed by a loss of 
CHs-(CH$HC=O [1,16]), and 402 (M+ - 180, 
loss of 2 x TMS-OH). The positions of the 
hydroxy groups at CS, Cl4 and Cl5 are indicated by 
the major fragment ions formed by cleavage of the 
carbon-carbon bonds on either side of the TMS-O- 
groups as shown in the inset in fig.4. In addition, 
secondary fragmentation of these ions (loss of 
TMS-OH, mass unit 90) were observed as in- 
dicated by the ions at m/z 83, 113, 185, 319 and 
421. Cleavage of the c7-cS bond and the Cri-Cl2 
bond is proposed for the ions at m/z 229 and 301, 
respectively. These data clearly indicate that prod- 
uct III is 5,14,15-trihydroxy-6,8,10,12-eicosatetra- 
enoic acid, a lipoxin B isomer. 
With arachidonic acid, 15-HETE and 15-HETE 
methyl ester as substrate this product was also 
formed as indicated by the spectral changes of the 
reaction mixture and RP-HPLC analysis of the 
products (not shown). For the formation of this 
product from 15-HETE methyl ester, it was shown 
that two atoms of atmospheric oxygen (“0) were 
incorporated into the product. This result excludes 
the possible formation of the lipoxin B isomer via 
epoxide hydrolysis. 
4. DISCUSSION 
The demonstration of the formation of a lipoxin 
B isomer by the pure reticulocyte lipoxygenase 
underlines the universal capacity of this enzyme 
with respect o the arachidonic acid metabolism via 
the lipoxygenase pathway. Previously we have 
demonstrated the formation of l%H(P)ETE, 
lZH(P)ETE, 5,15_DiH(P)ETE, 8,1$DiH(P)ETE, 
14,15-LT& and 13-hydroxy-14,1%epoxyeicosatet- 
raenoic acid [ 17- 191. Therefore the reticulocyte 
lipoxygenase is able to form compounds belonging 
to all important classes of lipoxygenase 
metabolites, such as hydroxyeicosanoids, epoxy- 
leukotrienes, lipoxins and hepoxiline isomers. 
In the biosynthesis of the naturally occurring 
lipoxin B an enzymatic hydrolysis of an epoxide in- 
termediate is involved [lo]. In contrast, the results 
presented here indicate that pure lipoxygenases are 
able to form lipoxins via dioxygenation of 
5,15-DiHETE, double dioxygenation of 1 !I-HETE 
or sequential triple dioxygenation of arachidonic 
acid. Similar results were obtained with the 
purified 12-lipoxygenase from white cells [20]. 
Leukocytes convert 15-HPETE, 15-HETE and 
5,15-DiHETE to lipoxin B [lo]. However, in 
previous studies on the lipoxin formation mainly 
15-HETE was used as substrate [2,3,6]. The use of 
5,15-DIHETE is recommended for several reasons: 
(i) this product has been identified as one of the 
major double oxygenation products formed by 
leukocytes and by pure lipoxygenases; (ii) an in- 
termediate formation of epoxy tetraenes is im- 
possible, therefore no complex product pattern is 
expected; (iii) the last step of the oxygenation 
cascade can be studied separately. 
Even though the absolute configuration of the 
chiral center Cl4 and the geometry of the con- 
jugated tetraene system were not elucidated by us 
(see Note Added in Proof), the steric structure of 
the product formed from SS,lSS-DiHETE can be 
predicted on the basis of the present knowledge on 
the stereochemistry of the lipoxygenase catalysis 
[21,22]. Considering the cis-lr0n.s isomerization 
following hydrogen removal, the direction bf the 
radical rearrangement, the antarafacial character 
[22,23] and the specificity of the reticulocyte en- 
zyme we propose the lipoxin B isomer formed by 
this lipoxygenase to be 5&14R,lSStrihydroxy- 
6E,8Z, lo,!?, 12.&eicosatetraenoic acid. This prod- 
uct represents a sequential triple lipoxygenation 
product of arachidonic acid but seems to be identi- 
cal to the most recently established structure for 
the naturally occurring lipoxin B which is formed 
via epoxide hydrolysis [lo]. 
NOTE ADDED IN PROOF 
In recent experiments the complete steric struc- 
ture of compound III has been elucidated by co- 
chromatography in RP-HPLC with the authentic 
standard of KS, 14R, 15s trihydroxy_6E,8Z, IOE, 
12E eicosatetraenoic acid. Therefore the identity 
of compound III with the lipoxin B formed by 
leukocytes has been established. The various 
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authentic standards of trihydroxyeicosanoids were 
obtained from Dr Fitzsimmons from Merck Frost, 
Canada. 
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